Perceived Impact of Cancer Treatment on Diabetes Self-Management

Hershey, Denise Soltow; Tipton, Janelle; Given, Barbara; Davis, Ellen D.

doi:10.1177/0145721712458835

Cited by 51 publications

(62 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As such, this is recognized as a hectic and burdensome time for patients. Prior qualitative work hypothesized that diabetes management becomes sidelined during this acute cancer care phase as the demands of cancer care overwhelm patients . Furthermore, oncologists are subspecialists whose focus is cancer, and the majority view the management of noncancer conditions such as diabetes as beyond their scope .…”

Section: Discussionmentioning

confidence: 99%

“…Comorbid diabetes puts patients with cancer at an increased risk of infections, hospitalizations, and mortality . Insufficient attention to diabetes during active cancer care may explain why diabetic patients with cancer have worse outcomes compared with their nondiabetic cancer counterparts . To our knowledge, few studies to date have documented diabetes management patterns among patients with cancer before and after their cancer diagnosis.…”

Section: Introductionmentioning

confidence: 99%

“…4,5 Insufficient attention to diabetes during active cancer care may explain why diabetic patients with cancer have worse outcomes compared with their nondiabetic cancer counterparts. 6,7 To our knowledge, few studies to date have documented diabetes management patterns among patients with cancer before and after their cancer diagnosis. This is important, because hyperglycemia and hyperinsulinemia may stimulate malignant tumor growth and thus cancer recurrence.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study

Pinheiro

Soroka

Kern

et al. 2020

Cancer

View full text Add to dashboard Cite

Background Diabetes places patients with cancer at an increased risk of infections, hospitalizations, and mortality. The objective of the current study was to characterize diabetes care management patterns among patients with cancer in the year before and, separately, after cancer diagnosis. The authors hypothesized that diabetes care declines after a diagnosis of cancer. Methods The Surveillance, Epidemiology, and End Results (SEER) cancer registry linked to Medicare claims data was used. The authors included diabetic beneficiaries aged ≥65 years who were diagnosed with incident, nonmetastatic breast, prostate, or colorectal cancer between 2008 and 2013. Controls were diabetic Medicare beneficiaries in SEER regions who did not have cancer. Cases were matched to controls based on age, sex, Charlson Comorbidity Index, and diabetes severity. Primary outcomes were diabetes care received over 12 months: 1) hemoglobin A1c testing; 2) eye examination; and 3) low‐density lipoprotein testing. Using a difference‐in‐difference (DID) approach, the authors examined use differences 12 months before to after diagnosis for patients with cancer and controls. To avoid capturing testing related to diagnosis and not diabetes management, the authors implemented a 90‐day washout period (45 days before and/or after diagnosis). Results A total of 32,728 diabetic patients with cancer and 32,728 matched noncancer controls were included. After diagnosis, patients with cancer were found to have modest, but significantly lower, rates of diabetes care use compared with controls. Patients with cancer had greater declines in hemoglobin A1c testing (DID, 2.4%; 95% CI, 1.7%‐3.0%), low‐density lipoprotein testing (DID, 4.3%; 95% CI, 3.6%‐5.0%), and receipt of all diabetes indicators (DID, 2.7%; 95% CI, 1.8%‐3.5%) 12 months before to after diagnosis. Conclusions Compared with controls, less diabetes care use was observed among patients with cancer in the year after diagnosis. Understanding and addressing the reasons for this may improve outcomes in this population.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study

Pinheiro

Soroka

Kern

et al. 2020

Cancer

View full text Add to dashboard Cite

show abstract

“…Previous research reported a higher prevalence of diabetes and suboptimal glycemic control in cancer survivors compared to noncancer survivors, and this varied by cancer types (Stava et al, 2007;Karlin et al, 2012). The reasons for this difference are not clear, but some studies have indicated that cancer treatment such as chemotherapy and cancerrelated symptoms could have a negative impact on diabetes management (Hershey et al, 2012). In addition, many medications used in cancer treatment or organ failure in advanced cancer patients can have an effect on glycemic control.…”

Section: Discussionmentioning

confidence: 99%

Prevalence, Awareness, Control, and Treatment of Hypertension and Diabetes in Korean Cancer Survivors: A Cross-Sectional Analysis of the Fourth and Fifth Korea National Health and Nutrition Examination Surveys

Choi

Park²,

Lee

et al. 2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: Management of hypertension and diabetes in cancer survivors is an important issue; however, not much is known about the level of management of such chronic disease in Korea. This study therefore assessed the prevalence, awareness, control, and treatment of hypertension and diabetes in Korean cancer survivors compared to non-cancer survivors. Materials and Methods: A cross-sectional design was employed, wherein data were obtained from standardized questionnaires completed by 943 cancer survivors and 41,233 non-cancer survivors who participated in the Fourth and Fifth Korea National Health and Nutrition Examination Surveys (2007-2011). We calculated adjusted proportions for prevalence and management of hypertension and diabetes in non-cancer survivors and cancer survivors. We also assessed the associated factors with prevalence and management of cancer survivors. Results: Cancer survivors are more likely than the general population to have higher prevalence, awareness, treatment, and control of hypertension. However, diabetic management was not significantly higher in cancer survivors than in non-cancer survivors, despite their having a higher prevalence. Several factors, such as, age, drinking, years since cancer diagnosis, self-perceived health status, and specific cancer types were found to affect to management of hypertension and diabetes. Conclusions: These data suggest that cancer survivors appear to be better than non-cancer survivors at management of hypertension, but not diabetes. There is a need for healthcare providers to recognize the importance of long-term chronic disease management for cancer survivors and for the care model to be shared between primary care physicians and oncologists.

show abstract

“…The associated symptoms, such as fatigue, nausea, and loss of appetite, which occur with chemotherapy, are likely to negatively impact an individual's ability to self-manage their diabetes, threatening glycemic control. 26 Individuals with more than 1 chronic illness may prioritize 1 chronic condition over the other, or the symptoms of 1 disorder may impact the actual performance of self-management behaviors required for another disorder. 8,27 Competing demands may develop from symptoms and care requirements associated with cancer and its treatment and impact the actual performance of required self-management activities for diabetes.…”

mentioning

confidence: 99%